Academic Bibliography

Show Sort by

Your filters: cql: parent exact "MELANOMA RESEARCH"

Mark
- conference
- C3
Cost-effectiveness of population-based skin cancer screening

Isabelle Hoorens (UGent) , Lore Pil (UGent) , Katrien Vossaert (UGent) , Lieven Annemans (UGent) and Lieve Brochez (UGent)

(2016) MELANOMA RESEARCH. 26(suppl. 1). p.E21-E21
Mark
Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib

Yanina J Jansen, Peter Janssens, Anne Hoorens (UGent) , Max S Schreuer, Teofila Seremet, Sofie Wilgenhof and Bart Neyns

(2015) MELANOMA RESEARCH. 25(6). p.550-554
Mark
Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?

INES CHEVOLET (UGent) , Max Schreuer (UGent) , Reinhart Speeckaert (UGent) , Bart Neyns, Isabelle Hoorens (UGent) , Nanja van Geel (UGent) , Vibeke Kruse (UGent) , Benjamin Hennart, Delphine Allorge, Mireille Van Gele (UGent) , et al.

(2015) MELANOMA RESEARCH. 25(4). p.357-361
Mark
- journalArticle
- A1
Proliferating endothelial cells, but not microvessel density, are a prognostic parameter in human cutaneous melanoma

Femke Hillen, Anouk van de Winkel, David Creytens (UGent) , Anton HM Vermeulen and Arjan W Griffioen

(2006) MELANOMA RESEARCH. 16(5). p.453-457
Mark
- journalArticle
- A1
The melanoma burden in Belgium; premature morbidity and mortality make melanoma a considerable health problem.

L BROCHEZ, Katrien Myny, T BLEYEN, Gui De Backer (UGent) and JM NAEYAERT

(1999) MELANOMA RESEARCH. 9(6). p.614-618
Mark
- journalArticle
- A2
Melanoma burden in Belgium: premature morbidity and mortality make melanoma a considerable health problem.

Lieve Brochez (UGent) , K MYNY, Luc Bleyen (UGent) , G DE BACKER and Jean Naeyaert

(1999) MELANOMA RESEARCH. 9. p.614-618
Mark
- journalArticle
- A1
Under-registration of melanoma in Belgium: an analysis.

L BROCHEZ, E VERHAEGHE, Luc Bleyen (UGent) , K MYNY, Gui De Backer (UGent) and Jean Naeyaert

(1999) MELANOMA RESEARCH. 9(4). p.413-418
Mark
- journalArticle
- A1
Primary sinonasal mucosal melanoma: three different therapeutic approaches to inoperable local disease or recurrence and a review of the literature.

Gert De Meerleer (UGent) , Hubert Vermeersch (UGent) , Marc Van Eijkeren (UGent) , Marc Lemmerling (UGent) , Jacques Caemaert (UGent) , B DE NAEYER, L DELRUE, M MOERMAN and John Huys (UGent)

(1998) MELANOMA RESEARCH. 8(5). p.449-457
Mark
- journalArticle
- A2
Late recurrence of malignant melanoma: a report of five cases, a review of the literature, and a study of associated factors.

E LEVY, M SILVERMAN, Katrien Vossaert, A KOPF, R BART and M LEVENSTEIN

(1991) MELANOMA RESEARCH. 1. p.63-67

Academic Bibliography

Cost-effectiveness of population-based skin cancer screening

Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib

Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?

Proliferating endothelial cells, but not microvessel density, are a prognostic parameter in human cutaneous melanoma

The melanoma burden in Belgium; premature morbidity and mortality make melanoma a considerable health problem.

Melanoma burden in Belgium: premature morbidity and mortality make melanoma a considerable health problem.

Under-registration of melanoma in Belgium: an analysis.

Primary sinonasal mucosal melanoma: three different therapeutic approaches to inoperable local disease or recurrence and a review of the literature.

Late recurrence of malignant melanoma: a report of five cases, a review of the literature, and a study of associated factors.

Contents

Support

Contact